Phibro Animal Health acquires MVP Laboratories

Phibro Animal Health acquires MVP Laboratories

Deal expands Phibro's animal vaccine business and gives it access to U.S.-based vaccine manufacturing facility.

Phibro Animal Health Corp. announced Jan. 12 an agreement to purchase the assets of MVP Laboratories Inc., a privately held developer, manufacturer and marketer of livestock vaccines, vaccine adjuvants and other products based in Omaha, Neb.

Acquiring the MVP business strengthens Phibro's core animal vaccine business and provides new opportunities in a fast-growing segment of the animal health industry, Phibro said in its announcement. In addition to other products, MVP manufacture

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit and click on Subscribe at the top of the page for more information.



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.